• EVMPs for Extrahepatic mRNA Delivery

  2026-08-31

  The reference study introduces a bottom-up, self-assembling enveloped virus-mimicking particle (EVMP) designed to overcome the hepatic bias of many mRNA delivery systems. By combining an engineered virus-mimicking peptide with selected phospholipids, the authors achieved lung and spleen targeting and demonstrated IL-12 mRNA activity in a metastatic lung tumor model.

• CRISPRi Targeting of Fabp4 in White Adipocytes

  2026-08-30

  Chung and colleagues developed a nonviral, adipose-targeted CRISPR interference system that silences Fabp4 selectively in mature white adipocytes. In obese mice, this strategy was associated with lower body weight and inflammation, improved hepatic steatosis, and better insulin-resistance phenotypes, highlighting tissue-specific gene repression as a potential approach to metabolic disorder research.

• Minocycline HCl as a Causal Probe in Retinal Research

  2026-08-29

  Minocycline HCl can do more than suppress microglia: it can help test whether immune-state changes causally influence retinal amyloid clearance and function. This article translates recent 40-Hz flicker findings into a rigorous, interpretation-focused assay strategy.

• Tubastatin A: HDAC6 Inhibitor Workflow

  2026-08-28

  Tubastatin A provides a selective way to connect HDAC6 signaling with microtubule stabilization, inflammation, cancer biology, and regulated cell death. This workflow translates recent porcine cardiac-resuscitation findings into practical assay design, controls, and troubleshooting decisions.

• 3-Deazaadenosine: A Strategic SAHH Probe

  2026-08-28

  3-Deazaadenosine hydrochloride offers translational researchers an upstream way to test whether methyl-metabolism pressure contributes to the IGF2BP1–TUBB4B–FAK program in hepatic stellate cells. This thought-leadership framework positions the compound as a mechanistic probe rather than a direct m6A inhibitor, with practical guidance for causal validation, assay design, and interpretation.

• AMPK–SQSTM1 Feedback in Metabolic Stress

  2026-08-27

  The reference study identifies a double-positive feedback loop in which metabolic stress activates SQSTM1/p62, while AMPK activity reinforces SQSTM1 expression and phosphorylation. This circuit coordinates lysosomal signaling, KEAP1 degradation, NRF2 activation, and AMPK-dependent metabolic adaptation, providing a mechanistic framework for understanding stress tolerance in STK11- and KEAP1-altered lung cancer.

• CCG-1423: RhoA Inhibitor Mechanism & Workflow

  2026-08-27

  CCG-1423 is a pathway-level RhoA inhibitor that disrupts MRTF-A importin α/β1 interaction while preserving MRTF-A binding to G-actin. Its research applications include cancer research, proliferation studies, invasion assays, and caspase-3 activation workflows.

• Triamcinolone (B1859): Practical Research Guide

  2026-08-26

  Triamcinolone (SKU B1859) is a synthetic glucocorticoid agonist for controlled in vitro studies of glucocorticoid receptor signaling, inflammation, and immunosuppression. This guide covers solubilization, storage, controls, and QC while defining boundaries: the compound is for scientific research only and is not intended for diagnostic, therapeutic, or clinical use.

• Hyaluronic Acid Sodium Salt in Translational Nanomedicine

  2026-08-26

  Hyaluronic acid sodium salt is more than a structural matrix ingredient: it can connect extracellular matrix mechanics, cell signaling, and targeted nucleic acid delivery. This thought-leadership analysis examines how sodium hyaluronate supports translational assay design and how a recent HA-coated siRNA nanoparticle study reframes its strategic value for infection and tissue-injury research.

• 3-Deazaadenosine Hydrochloride: Assay Logic

  2026-08-25

  3-Deazaadenosine hydrochloride is a S-adenosylhomocysteine hydrolase inhibitor for probing methylation-dependent biology. This article presents a rigorous assay framework connecting SAHH perturbation with the IGF2BP1–m6A–TUBB4B axis while separating pathway evidence from direct target claims.

• BFH772 (VEGFR2 inhibitor): Practical Guide

  2026-08-25

  BFH772 is a selective small-molecule VEGFR2 inhibitor for controlled studies of VEGFR2-mediated signaling and angiogenesis. Its organic-solvent solubility and defined kinase selectivity support pathway-focused workflows, but its water insolubility and limited evidence context make it unsuitable for water-based formulations, broad-spectrum kinase assays, or direct clinical inference.

• NET-DNA, CCDC25, and ILC3-Mediated Gut Repair

  2026-08-24

  A 2026 FASEB Journal study identifies a mechanistic pathway linking neutrophil extracellular trap DNA to impaired intestinal epithelial repair: NET-DNA activates CCDC25 in ILC3s and suppresses IL-22 production. The findings connect innate immune damage to mucosal barrier failure and suggest experimental strategies for separating NET-derived DNA effects from broader cell-free DNA activity.

• Vernakalant Hydrochloride: Assay Logic

  2026-08-24

  Vernakalant Hydrochloride, also known as RSD1235, offers a distinctive model for studying rapid conversion of atrial fibrillation through atrial-biased ion-channel pharmacology. This article develops an endpoint-first framework linking channel assays, exposure translation, and the pivotal phase 3 evidence.

• IGF2BP1–TUBB4B Signaling in Liver Fibrosis

  2026-08-23

  The reference study defines an m6A-dependent IGF2BP1–TUBB4B–FAK pathway that promotes hepatic stellate cell activation, proliferation, and migration. Its combination of transcriptomic re-analysis, RNA-binding and methylation profiling, genetic perturbation, and pharmacological testing offers a useful framework for studying post-transcriptional mechanisms in liver fibrosis.

• HCAR3 Cryo-EM Structures Explain Agonist Selectivity

  2026-08-22

  The 2025 PLOS Biology study resolves HCAR3–Gi complexes with four agonists and compares Acifran-bound HCAR3 and HCAR2, defining structural features that govern ligand recognition and receptor selectivity. Its combination of cryo-EM and cellular cAMP analysis provides a mechanistic framework for lipid signaling pathway modulation and for designing HCAR3-directed ligands with reduced HCAR2-linked liabilities.

8290 records 1/553 page Next 12345 下5页 Last page